{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:41:41Z","timestamp":1791636101159,"version":"4.3.4"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Iron deficiency and iron deficiency anemia (IDA) are prevalent during infancy. Timely iron prophylaxis can prevent associated irreversible complications. As part of the \u201cIron Like Turkey\u201d program initiated in April 2004, iron prophylaxis is administered from the fourth month of life for at least 5 months. This study aims to evaluate the implementation of iron prophylaxis in our country and compare the effectiveness of different iron preparations used in prophylaxis. Between January 2021 and January 2024, the iron prophylaxis status of 248 healthy, full-term, breastfed infants 9 to 15 months old who were referred to the Pediatric Hematology outpatient clinic of Manisa City Hospital for various reasons was assessed. Iron prophylaxis was administered to 204 (82.3%) infants, of whom 92 (44.1%) had irregular usage. Among those receiving iron prophylaxis, 110 (53.9%) used Fe+3, while 94 (46.1%) used Sucrosomial Iron (SI). No infants received Fe+2 for prophylaxis. Iron deficiency anemia (IDA) was present in 142 (57.3%) cases. No significant difference was found between Fe<jats:sup>+3<\/jats:sup>and Sucrosomial Iron in terms of adherence and duration of prophylaxis (<jats:italic toggle=\"yes\">P<\/jats:italic>&gt;0.05). However, hemoglobin (Hb), mean corpuscular volume (MCV), ferritin, and transferrin saturation levels were significantly lower in the Sucrosomial Iron group compared with the Fe<jats:sup>+3<\/jats:sup> group (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05). Iron prophylaxis is an easy and effective method to prevent IDA. Both mothers during pregnancy and infants should receive prophylaxis on time and for an adequate duration. Further research is needed to evaluate the efficacy of different iron formulations used in prophylaxis.<\/jats:p>","DOI":"10.1097\/mph.0000000000003111","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:00:33Z","timestamp":1755694833000},"page":"347-351","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Comparing Iron Prophylaxis Strategies in Infants: Is Sucrosomial Iron a Better Alternative?"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5768-0890","authenticated-orcid":false,"given":"Sultan","family":"Okur Acar","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Manisa City Hospital, Manisa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neryal","family":"Tahta","sequence":"additional","affiliation":[{"name":"\u0130zmir City Hospital, Department of Pediatric Hematology and Oncology, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"R1-20250925","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1542\/peds.2010-2576","article-title":". Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age)","volume":"126","author":"Baker","year":"2010","journal-title":"Pediatrics"},{"key":"R2-20250925","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1016\/S2352-3026(23)00160-6","article-title":"Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"key":"R5-20250925","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/ph16060847","article-title":"Sucrosomial\u00ae iron: an updated review of its clinical efficacy for the treatment of iron deficiency","volume":"16","author":"G\u00f3mez-Ram\u00edrez","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"R7-20250925","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.actatropica.2007.11.007","article-title":"Fighting anaemia and malnutrition in Hebron (Palestine): impact evaluation of a humanitarian project","volume":"105","author":"Magoni","year":"2008","journal-title":"Acta Trop"},{"key":"R8-20250925","first-page":"16","article-title":"A community-based iron supplementation program, \u201cIron-Like Turkey\u201d, and the following prevalence of anemia among infants aged 12-23 months","volume":"55","author":"Yal\u00e7in","year":"2013","journal-title":"Turk J Pediatr"},{"key":"R9-20250925","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MPH.0000000000000967","article-title":"Comparison of different iron preparations in the prophylaxis of iron-deficiency anemia","volume":"39","author":"Aydin","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"R10-20250925","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MPH.0b013e3181ec0f2c","article-title":"Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy","volume":"32","author":"Jaber","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"R11-20250925","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3390\/healthcare12101043","article-title":"Use of different iron preparations for prophylaxis and effects on iron status in infancy","volume":"12","author":"Tosyali","year":"2024","journal-title":"Healthcare (Basel)"},{"key":"R12-20250925","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jamapediatrics.2024.1095","article-title":"Effect of low-dose iron supplementation on early development in breastfed infants: a randomized clinical trial","volume":"178","author":"Svensson","year":"2024","journal-title":"JAMA Pediatr"},{"key":"R13-20250925","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/gfu357","article-title":"Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial","volume":"30","author":"Pisani","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R14-20250925","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11096-020-01044-x","article-title":"Treatment of iron deficiency anemia with liposomal iron in inflammatory bowel disease: efficacy and impact on quality of life","volume":"42","author":"de Alvarenga Antunes","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"R15-20250925","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/nu10101349","article-title":"Sucrosomial\u00ae iron supplementation in mice: effects on blood parameters, hepcidin, and inflammation","volume":"10","author":"Asperti","year":"2018","journal-title":"Nutrients"},{"key":"R16-20250925","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/nu13020608","article-title":"Oral sucrosomial iron is as effective as intravenous ferric carboxy-maltose in treating anemia in patients with ulcerative colitis","volume":"13","author":"Bertani","year":"2021","journal-title":"Nutrients"},{"key":"R17-20250925","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2214-109X(13)70046-9","article-title":"Effect of daily iron supplementation on health in children aged 4-23 months: a systematic review and meta-analysis of randomised controlled trials","volume":"1","author":"Pasricha","year":"2013","journal-title":"Lancet Glob Health"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:00:52Z","timestamp":1758801652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003111","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"2025-05-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}